The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
Catherine Liloia
Advertisement
Catherine Liloia, Catherine.Liloia@ppd.com, is director at PPD Laboratories’ GMP cell lab.
Articles by Catherine Liloia
Advertisement
Latest Updated Articles
Development Strategies for Cell and Gene Therapy MethodsPublished: June 1st 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
E&L Challenges in Biologics, Part One
2
BioPharm Weekly News Roundup—Week of Nov. 10, 2025
3
E&L Challenges in Biologics, Part Two
4
Survey: Biopharma Impacts of the Commissioner's National Priority Vouchers Program
5
